Purpose

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Previously treated or treatment naïve patients with a documented diagnosis of macular edema associated with diabetic retinopathy (DR) in the study eye, with onset of disease that began at any time prior to the Screening Visit. - Best-corrected visual acuity (BCVA) Early Treatment Diabetic Retinopathy Study (ETDRS) letter score of 35 letters (20/200 Snellen equivalent) to 78 letters (20/32 Snellen equivalent) in the study eye at the Screening Visit and at Baseline (Day 1). - For previously treated participants: at least 1 injection of anti-VEGF in the past 12 months, the most recent anti-VEGF treatment for DME must not have been administered less than 12 weeks prior to the Screening Visit.

Exclusion Criteria

  • BCVA using ETDRS charts <30 letters (20/250 Snellen equivalent) in the fellow eye.

Study Design

Phase
Phase 3
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
EYP-1901 2686 µg
EYP-1901
  • Drug: EYP-1901
    Intravitreal Injection
Active Comparator
Aflibercept
  • Drug: Aflibercept (2.0 mg)
    Intravitreal Injection

Recruiting Locations

California Retina Consultants
Bakersfield, California 93309
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

The Retina Partners
Encino, California 91436
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Global Research Management, Inc.
Glendale, California 91204
Contact:
Clinical Project Manager
833-393-7646
info@eyepointpharma.com

Northern California Retina Vitreous Associates Medical Group INC.
Mountain View, California 94040
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Consultants of San Diego
Poway, California 92064
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

California Eye Specialists Medical Group, Inc.
Redlands, California 92373
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retinal Consultants Medical Group - Parkcenter Drive
Sacramento, California 95825
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retinal Consultants Medical Group
Sacramento, California 95841
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Colorado Retina Associates
Lakewood, Colorado 80228
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Advance Medical Research Group, Inc
Deerfield Beach, Florida 33064
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Eye Associates of Pinellas
Pinellas Park, Florida 33782
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Southern Vitreoretinal Associates
Tallahassee, Florida 32308
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Specialists of Tampa
Wesley Chapel, Florida 33544
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Georgia Retina
Marietta, Georgia 30060
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Consultants of Hawaii
‘Aiea, Hawaii 96701
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Red River Research Partners
Plainfield, Illinois 60586
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Midwest Eye Institute - Carmel
Carmel, Indiana 11220
Contact:
Clinical Project Manager
833-393-7646
info@eyepointpharma.com

Haik Humble Eye Center
West Monroe, Louisiana 71291
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

New England Retina Consultants
Springfield, Massachusetts 01107
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Associates of Michigan
Grand Blanc, Michigan 48439
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Foundation for Vision Research
Grand Rapids, Michigan 49546
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

NJ Retina - Toms River
Toms River, New Jersey 08755
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Associates of Western New York
Rochester, New York 14620
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

VRCNY/Long Island Vitreoretinal Consultants
Westbury, New York 11590
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Asheville Eye Associates - Regional Medical Park
Asheville, North Carolina 28803
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Cape Fear Retinal Associates, PC
Wilmington, North Carolina 28401
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Piedmont Retina Specialists, P.A. - Winston-Salem Office
Winston-Salem, North Carolina 27103
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Tulsa Retina Consultant
Tulsa, Oklahoma 74114
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Erie Retina Research
Erie, Pennsylvania 16507
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Charleston Neuroscience Institute - Beaufort
Beaufort, South Carolina 29902
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Tennessee Retina
Nashville, Tennessee 37203
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Research Institute of Texas Integrated Clinical Research
Abilene, Texas 79606
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Texas Retina Associates
Dallas, Texas 75231
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Mt. Olympus Medical Research
Houston, Texas 77479
Contact:
Clinical Project Manager
833-393-7646
info@eyepointpharma.com

Retina Consultants of Texas
Katy, Texas 77494
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Texas Retina Associates
Plano, Texas 75075
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Retina Consultants of Texas
Schertz, Texas 78154
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Salt Lake Retina
West Jordan, Utah 84088
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

Piedmont Eye Center
Lynchburg, Virginia 24502
Contact:
Clinical Project Manager
1.833.393.7646
info@eyepointpharma.com

More Details

Status
Recruiting
Sponsor
EyePoint Pharmaceuticals, Inc.

Study Contact

Ramiro Ribeiro, MD, PhD
833-393-7646
rribeiro@eyepoint.bio

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.